DREDGECAP
NASDAQ·Biological Products, (No Diagnostic Substances)
OKYO

OKYO Pharma Ltd

OKYO Pharma Ltd (ticker: OKYO) is an NASDAQ-listed biological products, (no diagnostic substances) company. DredgeCap's structured extraction of OKYO's SEC filings surfaces 6 active risk signals, including 3 auditor-change signals, and 3 late-filing signals. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.

OKYO SEC Filings

Full cached SEC EDGAR filing history for OKYO, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.

No cached filings for OKYO. Check SEC EDGAR directly:
View OKYO on SEC EDGAR ↗
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.